Western Sweden joins forces to strengthen Swedish life science

CCRM Nordic is proud to be one of the organizations signing the joint declaration of intent to strengthen and accelerate the life science ecosystem in Western Sweden.

The initiative brings together leading stakeholders from industry, academia, healthcare, and the public sector with a shared ambition to enhance innovation, competitiveness, and collaboration across the region. By establishing a joint council for Western Swedish life science, the partners aim to create stronger conditions for research, clinical development, manufacturing, and patient access to new therapies.

Read the full press release here: https://www.businessregiongoteborg.se/nyheter/vastsverige-kraftsamlar-att-lyfta-svensk-life-science

Contacts

Fredrik Wessberg, fredrik.wessberg@ccrmnordic.se 

About CCRM Nordic:

CCRM Nordic is a leading organization dedicated to advancing research, development, and commercialization of advanced therapy medicinal products (ATMPs). With a focus on innovation and collaboration, CCRM Nordic strives to accelerate the translation of scientific discoveries into tangible therapies that address unmet medical needs.

About CCRM:

CCRM is a global, public-private partnership headquartered in Canada, established with seed funding provided by the Government of Canada, the Province of Ontario, and leading academic and industry partners. CCRM supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. A network of researchers, leading companies, investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, dedicated funding, and unique infrastructure. In 2022, CCRM established OmniaBio Inc., a pre-clinical to commercial-stage CDMO for manufacturing gene-modified cells and viral vectors for cell and gene therapies. CCRM is hosted by the University of Toronto. Visit at ccrm.ca